Novavax Covid-19 Vaccine Faces Delay

Novavax Covid-19 Vaccine Faces Delay
·4 min read

A shortage of raw materials will push back several regulatory and manufacturing targets for the vaccine, which is in the final stage of testing.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting